Koganti R - Search Results

1

Standalone or combinatorial phenylbutyrate therapy shows excellent antiviral activity and mimics CREB3 silencing.

Yadavalli T, Suryawanshi R, Koganti R, Hopkins J, Ames J, Koujah L, Iqbal A, Madavaraju K, Agelidis A, Shukla D. Yadavalli T, et al. Among authors: koganti r. Sci Adv. 2020 Dec 4;6(49):eabd9443. doi: 10.1126/sciadv.abd9443. Print 2020 Dec. Sci Adv. 2020. PMID: 33277262 Free PMC article.

2

Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections.

Koganti R, Yadavalli T, Shukla D. Koganti R, et al. Microorganisms. 2019 Oct 10;7(10):429. doi: 10.3390/microorganisms7100429. Microorganisms. 2019. PMID: 31658632 Free PMC article. Review.

3

Prior inhibition of AKT phosphorylation by BX795 can define a safer strategy to prevent herpes simplex virus-1 infection of the eye.

Yadavalli T, Suryawanshi R, Ali M, Iqbal A, Koganti R, Ames J, Aakalu VK, Shukla D. Yadavalli T, et al. Among authors: koganti r. Ocul Surf. 2020 Apr;18(2):221-230. doi: 10.1016/j.jtos.2019.11.011. Epub 2019 Nov 23. Ocul Surf. 2020. PMID: 31770600 Free PMC article.

4

Heparanase-Regulated Syndecan-1 Shedding Facilitates Herpes Simplex Virus 1 Egress.

Hadigal S, Koganti R, Yadavalli T, Agelidis A, Suryawanshi R, Shukla D. Hadigal S, et al. Among authors: koganti r. J Virol. 2020 Feb 28;94(6):e01672-19. doi: 10.1128/JVI.01672-19. Print 2020 Feb 28. J Virol. 2020. PMID: 31827001 Free PMC article.

5

Heparanase, cell signaling, and viral infections.

Koganti R, Suryawanshi R, Shukla D. Koganti R, et al. Cell Mol Life Sci. 2020 Dec;77(24):5059-5077. doi: 10.1007/s00018-020-03559-y. Epub 2020 May 27. Cell Mol Life Sci. 2020. PMID: 32462405 Free PMC article. Review.

6

Vaccines and Therapies in Development for SARS-CoV-2 Infections.

Wu D, Koganti R, Lambe UP, Yadavalli T, Nandi SS, Shukla D. Wu D, et al. Among authors: koganti r. J Clin Med. 2020 Jun 16;9(6):1885. doi: 10.3390/jcm9061885. J Clin Med. 2020. PMID: 32560227 Free PMC article. Review.

7

Infection-Induced Porcine Ex Vivo Corneal Wound Model to Study the Efficacy of Herpes Simplex Virus-1 Entry and Replication Inhibitors.

Yadavalli T, Koganti R, Shukla D. Yadavalli T, et al. Among authors: koganti r. Methods Mol Biol. 2021;2193:183-196. doi: 10.1007/978-1-0716-0845-6_18. Methods Mol Biol. 2021. PMID: 32808270

8

Pharmaceutically Acceptable Carboxylic Acid-Terminated Polymers Show Activity and Selectivity against HSV-1 and HSV-2 and Synergy with Antiviral Drugs.

Yadavalli T, Mallick S, Patel P, Koganti R, Shukla D, Date AA. Yadavalli T, et al. Among authors: koganti r. ACS Infect Dis. 2020 Nov 13;6(11):2926-2937. doi: 10.1021/acsinfecdis.0c00368. Epub 2020 Oct 20. ACS Infect Dis. 2020. PMID: 33078609 Free PMC article.

9

Dysregulation of Cell Signaling by SARS-CoV-2.

Suryawanshi RK, Koganti R, Agelidis A, Patil CD, Shukla D. Suryawanshi RK, et al. Among authors: koganti r. Trends Microbiol. 2021 Mar;29(3):224-237. doi: 10.1016/j.tim.2020.12.007. Epub 2020 Dec 19. Trends Microbiol. 2021. PMID: 33451855 Free PMC article. Review.

10

Herpes Simplex Virus Cell Entry Mechanisms: An Update.

Madavaraju K, Koganti R, Volety I, Yadavalli T, Shukla D. Madavaraju K, et al. Among authors: koganti r. Front Cell Infect Microbiol. 2021 Jan 18;10:617578. doi: 10.3389/fcimb.2020.617578. eCollection 2020. Front Cell Infect Microbiol. 2021. PMID: 33537244 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page